The drug ketamine is being repurposed in a new clinical trial at the University of Arizona College of Medicine-Tucson, supported by the Arizona Biomedical Research Commission, to potentially help Parkinson’s disease patients who are taking the drug Levodopa have fewer side effects.

Eric Miller, principal at Tempe-based PADT Inc., writes that Arizona must seek additional pay incentives for STEM teachers, an issue important to tech companies because the state’s growth and success is based on the quality of the employees.